Review:
When the U.S. Supreme Court ruled in 1980 that new life forms could be patented, biology escaped the confines of academia; biotechnology companies have been multiplying like hothouse organisms ever since. The conjunction of scientific research and corporate profits has created much angst, not least among working scientists. Paul Rabinow, an anthropologist, decided to research not some Pacific island tribe but this new breed of scientists in their natural habitat--a hot new biotechnology company. He chose Cetus, a company that developed a procedure called the polymerase chain reaction, or PCR, a method for replicating large amounts of DNA from tiny samples. His account of the benefits of the commercial approach to research, and of the conflicts over prestige and money, is well-balanced and original.
From the Back Cover:
Making PCR is the fascinating, behind-the-scenes account of the invention of one of the most significant biotech discoveries of our time - the polymerase chain reaction. Skillfully blending narrative description and interviews with all the major players, Paul Rabinow explores what it means to be a "scientist" today, the effects of doing science in the high-risk, high-reward environment of biotech, and what a scientific discovery or invention is at a time when it is possible to patent life itself. PCR has profoundly transformed the practices and potential of molecular biology by extending scientists' ability to identify and manipulate genetic material. It facilitates the identification of precise segments of DNA and accurately reproduces millions of copies of the given segment in a short period of time. In sum, Making PCR shows how a contingently assembled practice emerged, composed of distinctive subjects, the site in which they worked, and the object they invented.
"About this title" may belong to another edition of this title.